Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - FREE CASH FLOW
Free Cash Flow HALO - Halozyme Therapeutics, Inc.
373 M
LAST VALUE
11.92%
2 YEAR CAGR
54.81%
5 YEAR CAGR
24.89%
10 YEAR CAGR